Why the study?
Despite significant improvements in heart failure treatment, relatively little is known about the complex interactions in heart failure, particularly in heart failure with preserved ejection fraction.
A review of the evolution and future directions of heart failure therapies, highlighting the shift towards combining pharmacotherapy with biotechnology, nanotechnology, and digital health.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Rosano et al. (2023) conducted a review in Heart failure. Heart failure therapies was evaluated.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: